Drug profile · INN
sulfasalazine
PYRALIN EN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
sulfasalazine (PYRALIN EN) is an FDA-listed pharmaceutical active ingredient. Associated with Pfizer Australia Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN sulfasalazine
Brand PYRALIN EN
Route ORAL
Formulation TABLET, DELAYED RELEASE
Originator Pfizer Australia Pty Ltd
Frequently asked questions
What is sulfasalazine?
sulfasalazine (PYRALIN EN) is an FDA-listed pharmaceutical active ingredient. Associated with Pfizer Australia Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sulfasalazine?
PYRALIN EN is a marketed brand name for sulfasalazine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sulfasalazine?
sulfasalazine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.